nimodipine has been researched along with Extravascular Hemolysis in 2 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, H | 1 |
| Katada, K | 1 |
| Orita, M | 1 |
| Nishikibe, M | 1 |
| Fleckenstein-Grün, G | 1 |
| Fleckenstein, A | 1 |
2 other studies available for nimodipine and Extravascular Hemolysis
| Article | Year |
|---|---|
Effects of calcium antagonists on the erythrocyte membrane.
Topics: Animals; Calcium Channel Blockers; Dihydropyridines; Erythrocyte Membrane; Hemolysis; Male; Microsco | 1991 |
Prevention of cerebrovascular spasms with nimodipine.
Topics: Animals; Basilar Artery; Brain; Calcium; Coronary Vessels; Guinea Pigs; Hemolysis; Ischemic Attack, | 1990 |